Showing results (471-480 of 528) with videos related to
Sort By:
Pageof 53
Neurogastroenterology and Motility|May 20, 2016
Irritable bowel syndrome and the perinatal period: lower birth weight increases the riskD Raslau, L M Herrick, G R Locke, et al.Alimentary Pharmacology & Therapeutics|August 22, 2006
Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteersN J Talley, M Camilleri, D Burton, et al.Alimentary Pharmacology & Therapeutics|August 19, 2007
Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?N J Talley, N Vakil, K Lauritsen, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 17, 2024
Diabetes distress and depression are independently associated with gastrointestinal symptoms in type 2 diabetes in BangladeshM Kamruzzaman, M Horowitz, W H Polonsky, et al.Aging Cell|February 19, 2020
Sexual dimorphism in the nutritional requirement for adult lifespan in Drosophila melanogasterQi Wu, Guixiang Yu, Xingyi Cheng, et al.Alimentary Pharmacology & Therapeutics|February 24, 2001
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 monthsN J Talley, K Lauritsen, H Tunturi-Hihnala, et al.Scandinavian Journal of Gastroenterology|March 4, 2005
Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score QuestionnaireP Aro, J Ronkainen, T Storskrubb, et al.Alimentary Pharmacology & Therapeutics|April 1, 2006
Predictors of the placebo response in functional dyspepsiaN J Talley, G R Locke, B D Lahr, et al.The American Journal of Gastroenterology|April 1, 1996
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trialsS J Veldhuyzen van Zanten, C Cleary, N J Talley, et al.Alimentary Pharmacology & Therapeutics|February 3, 2007
The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-siteS J Crane, G Richard Locke, W S Harmsen, et al.Pageof 53